BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37704381)

  • 21. Assessment of Clinicopathological Characteristics and Development of an Individualized Prognostic Model for Patients With Hepatoid Adenocarcinoma of the Stomach.
    Lin JX; Wang ZK; Hong QQ; Zhang P; Zhang ZZ; He L; Wang Q; Shang L; Wang LJ; Sun YF; Li ZX; Liu JJ; Ding FH; Lin ED; Fu YA; Lin SM; Xie JW; Li P; Zheng CH; Huang CM
    JAMA Netw Open; 2021 Oct; 4(10):e2128217. PubMed ID: 34609494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinetic Heterogeneity of Breast Cancer Determined Using Computer-aided Diagnosis of Preoperative MRI Scans: Relationship to Distant Metastasis-Free Survival.
    Kim JY; Kim JJ; Hwangbo L; Suh HB; Kim S; Choo KS; Nam KJ; Kang T
    Radiology; 2020 Jun; 295(3):517-526. PubMed ID: 32228293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is evaluation of the presence of prepectoral edema on T2-weighted with fat-suppression 3 T breast MRI a simple and readily available noninvasive technique for estimation of prognosis in patients with breast cancer?
    Uematsu T; Kasami M; Watanabe J
    Breast Cancer; 2014 Nov; 21(6):684-92. PubMed ID: 23341125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy.
    Caudle AS; Yu TK; Tucker SL; Bedrosian I; Litton JK; Gonzalez-Angulo AM; Hoffman K; Meric-Bernstam F; Hunt KK; Buchholz TA; Mittendorf EA
    Breast Cancer Res; 2012 May; 14(3):R83. PubMed ID: 22621334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term survival outcomes in invasive lobular carcinoma patients with and without preoperative MR imaging: a matched cohort study.
    Ha SM; Chae EY; Cha JH; Kim HH; Shin HJ; Choi WJ
    Eur Radiol; 2019 May; 29(5):2526-2534. PubMed ID: 30617471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphovascular invasion has a significant prognostic impact in patients with early breast cancer, results from a large, national, multicenter, retrospective cohort study.
    Houvenaeghel G; Cohen M; Classe JM; Reyal F; Mazouni C; Chopin N; Martinez A; Daraï E; Coutant C; Colombo PE; Gimbergues P; Chauvet MP; Azuar AS; Rouzier R; Tunon de Lara C; Muracciole X; Agostini A; Bannier M; Charaffe Jauffret E; De Nonneville A; Goncalves A
    ESMO Open; 2021 Dec; 6(6):100316. PubMed ID: 34864349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative prediction of lymphovascular invasion in invasive breast cancer with dynamic contrast-enhanced-MRI-based radiomics.
    Liu Z; Feng B; Li C; Chen Y; Chen Q; Li X; Guan J; Chen X; Cui E; Li R; Li Z; Long W
    J Magn Reson Imaging; 2019 Sep; 50(3):847-857. PubMed ID: 30773770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can enhancement types on preoperative MRI reflect prognostic factors and surgical outcomes in invasive breast cancer?
    Koh J; Park AY; Ko KH; Jung HK
    Eur Radiol; 2019 Dec; 29(12):7000-7008. PubMed ID: 31187220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preoperative breast MRI for early-stage breast cancer: effect on surgical and long-term outcomes.
    Sung JS; Li J; Da Costa G; Patil S; Van Zee KJ; Dershaw DD; Morris EA
    AJR Am J Roentgenol; 2014 Jun; 202(6):1376-82. PubMed ID: 24848838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiparametric MRI-based radiomics nomogram for preoperative prediction of lymphovascular invasion and clinical outcomes in patients with breast invasive ductal carcinoma.
    Zhang J; Wang G; Ren J; Yang Z; Li D; Cui Y; Yang X
    Eur Radiol; 2022 Jun; 32(6):4079-4089. PubMed ID: 35050415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term Survival Outcomes of Primary Breast Cancer in Women With or Without Preoperative Magnetic Resonance Imaging: A Matched Cohort Study.
    Choi WJ; Cha JH; Kim HH; Shin HJ; Chae EY; Jung KH; Ahn JH; Kim SB; Son BH; Ahn SH
    Clin Oncol (R Coll Radiol); 2017 Oct; 29(10):653-661. PubMed ID: 28728883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of Breast Edema Findings at T2-weighted Breast MRI Is Useful for Diagnosing Occult Inflammatory Breast Cancer and Can Predict Prognosis after Neoadjuvant Chemotherapy.
    Harada TL; Uematsu T; Nakashima K; Kawabata T; Nishimura S; Takahashi K; Tadokoro Y; Hayashi T; Tsuchiya K; Watanabe J; Sugino T
    Radiology; 2021 Apr; 299(1):53-62. PubMed ID: 33560188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast parenchymal signal enhancement ratio at preoperative magnetic resonance imaging: association with early recurrence in triple-negative breast cancer patients.
    Park VY; Kim EK; Kim MJ; Yoon JH; Moon HJ
    Acta Radiol; 2016 Jul; 57(7):802-8. PubMed ID: 26516288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymph node ratio as best prognostic factor in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy.
    De la Cruz-Ku GA; Chambergo-Michilot D; Valcarcel B; Rebaza P; Möller M; Araujo JM; Enriquez D; Morante Z; Razuri C; Luque R; Saavedra A; Eyzaguirre E; Lujan M; Noel N; Pinto J; Cotrina J; Gomez H
    Breast J; 2020 Sep; 26(9):1659-1666. PubMed ID: 32713113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive value of T2-weighted magnetic resonance imaging for the prognosis of patients with mass-type breast cancer with peritumoral edema.
    Liang T; Hu B; Du H; Zhang Y
    Oncol Lett; 2020 Dec; 20(6):314. PubMed ID: 33133250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microcalcifications and Peritumoral Edema Predict Survival Outcome in Luminal Breast Cancer Treated with Neoadjuvant Chemotherapy.
    Kwon BR; Shin SU; Kim SY; Choi Y; Cho N; Kim SM; Yi A; Yun B; Jang M; Ha SM; Lee SH; Chang JM; Moon WK
    Radiology; 2022 Aug; 304(2):310-319. PubMed ID: 35536129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Analysis of risk factors of axillary lymph node metastasis and prognosis in T1 breast cancer: a large-scale retrospective study based on the SEER database].
    Wang WY; Meng XZ; Li N; Zeng HM; Liu JX; Feng KX; Wang PL; Wang X
    Zhonghua Yi Xue Za Zhi; 2021 Jul; 101(27):2152-2158. PubMed ID: 34275251
    [No Abstract]   [Full Text] [Related]  

  • 38. The role of lymphovascular invasion as a prognostic factor in patients with lymph node-positive operable invasive breast cancer.
    Song YJ; Shin SH; Cho JS; Park MH; Yoon JH; Jegal YJ
    J Breast Cancer; 2011 Sep; 14(3):198-203. PubMed ID: 22031801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Added Value of MRI for Invasive Breast Cancer including the Entire Axilla for Evaluation of High-Level or Advanced Axillary Lymph Node Metastasis in the Post-ACOSOG Z0011 Trial Era.
    Byon JH; Park YV; Yoon JH; Moon HJ; Kim EK; Kim MJ; You JK
    Radiology; 2021 Jul; 300(1):46-54. PubMed ID: 33904772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Long-term recurrence rate and survival in different aged patients with breast cancer undergoing breast conserving therapy].
    Wang LZ; Li JF; Wang TF; Xie YT; Fan ZQ; He YJ; Ouyang T
    Zhonghua Wai Ke Za Zhi; 2021 Feb; 59(2):127-133. PubMed ID: 33378805
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.